This inventor holds 1 USPTO granted patent. Top assignees: Charité – Universitätsmedizin Berlin, Fondazione Istituto Italiano Di Tecnologia. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:


Years Active: 2022
Title: Giuseppe Maria Paterno′: Innovator in Photochromic Compounds
Introduction
Giuseppe Maria Paterno′ is a notable inventor based in Enna, Italy. He has made significant contributions to the field of eye disorders through his innovative research and development of photochromic compounds. His work has the potential to impact medical treatments and improve patient outcomes.
Latest Patents
Giuseppe Maria Paterno′ holds a patent for "Photochromic compounds for use in the treatment of eye disorders." This patent includes compounds with a specific formula wherein Y and Z are independently O, N, or P. The compounds may also contain optionally substituted C-Calkyl, O, or R, forming a 3-14 membered ring. Additionally, these compounds can include one or more heteroatoms selected from O, N, and S, which may also be substituted. The compositions derived from these compounds have various medical uses, particularly in treating eye disorders.
Career Highlights
Throughout his career, Giuseppe has worked with esteemed institutions such as the Fondazione Istituto Italiano Di Tecnologia and Politecnico Di Milano. His experience in these organizations has allowed him to advance his research and collaborate with other experts in the field.
Collaborations
Giuseppe Maria Paterno′ has collaborated with notable colleagues, including Guglielmo Lanzani and Francesco Lodola. These partnerships have contributed to the development and refinement of his innovative compounds.
Conclusion
Giuseppe Maria Paterno′ is a distinguished inventor whose work in photochromic compounds holds promise for the treatment of eye disorders. His contributions to the field reflect his dedication to advancing medical science and improving patient care.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile